Literature DB >> 27777980

Ly6Chi monocytes regulate T cell responses in viral hepatitis.

Jiangao Zhu1, Huiyao Chen2, Xiaopei Huang1, Songfu Jiang2, Yiping Yang1,3.   

Abstract

Viral hepatitis remains a global health challenge despite recent progress in the development of more effective therapies. Although virus-specific CD8+ and CD4+ T cell responses are essential for viral clearance, it remains largely unknown what regulates T cell-mediated viral clearance. Thus, a better understanding of the regulation of anti-viral T cell immunity would be critical for the design of more effective therapies for viral hepatitis. Using a model of adenovirus-induced hepatitis, here we showed that adenoviral infection induced recruitment of Ly6Chi monocytes to the liver in a CCR2-dependent manner. These recruited Ly6Chi monocytes suppressed CD8+ and CD4+ T cell responses to adenoviral infection, leading to a delay in viral clearance. In vivo depletion of Ly6Chi monocytes markedly enhanced anti-viral T cell responses and promoted viral clearance. Mechanistically, we showed that induction of iNOS and the production of NO by Ly6Chi monocytes are critical for the suppression of T cell responses. In addition, a contact-dependent mechanism mediated by PD-1 and PD-L1 interaction is also required for T cell suppression by Ly6Chi monocytes. These findings suggest a critical role for Ly6Chi monocytes in the regulation of T cell immunity in viral hepatitis and may provide new insights into development of more effective therapies for treating viral hepatitis based on targeting the immunosuppressing monocytes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27777980      PMCID: PMC5070953          DOI: 10.1172/jci.insight.89880

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  39 in total

1.  STAT1 is required for iNOS activation, but not IL-6 production in murine fibroblasts.

Authors:  T Samardzic; V Jankovic; S Stosic-Grujicic; V Trajkovic
Journal:  Cytokine       Date:  2001-02-07       Impact factor: 3.861

Review 2.  Cellular and molecular basis of the protective immune response to cytomegalovirus infection.

Authors:  U H Koszinowski; M Del Val; M J Reddehase
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways.

Authors:  Jiangao Zhu; Xiaopei Huang; Yiping Yang
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 4.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

5.  Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

Authors:  Y Yang; K U Jooss; Q Su; H C Ertl; J M Wilson
Journal:  Gene Ther       Date:  1996-02       Impact factor: 5.250

6.  Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.

Authors:  Jenna L Bowen; Julie K Olson
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

7.  CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.

Authors:  Yanmei Han; Qiuli Guo; Minggang Zhang; Zhubo Chen; Xuetao Cao
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection.

Authors:  Michael Quigley; Jennifer Martinez; Xiaopei Huang; Yiping Yang
Journal:  Blood       Date:  2008-10-23       Impact factor: 22.113

9.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

10.  Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior.

Authors:  Cedric Auffray; Darin Fogg; Meriem Garfa; Gaelle Elain; Olivier Join-Lambert; Samer Kayal; Sabine Sarnacki; Ana Cumano; Gregoire Lauvau; Frederic Geissmann
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

View more
  5 in total

1.  Group B streptococci infection model shows decreased regulatory capacity of cord blood cells.

Authors:  Kriszta Molnar; Hannah Riedel; Julian Schwarz; Stefanie Dietz; Bärbel Spring; Laura Haag; Christian F Poets; Christian Gille; Natascha Köstlin-Gille
Journal:  Pediatr Res       Date:  2022-02-14       Impact factor: 3.756

2.  Humoral immune response to adenovirus induce tolerogenic bystander dendritic cells that promote generation of regulatory T cells.

Authors:  Thi Thu Phuong Tran; Karsten Eichholz; Patrizia Amelio; Crystal Moyer; Glen R Nemerow; Matthieu Perreau; Franck J D Mennechet; Eric J Kremer
Journal:  PLoS Pathog       Date:  2018-08-20       Impact factor: 6.823

3.  Anti-inflammatory consequences of bile acid accumulation in virus-infected bile duct ligated mice.

Authors:  Stephanie Rattay; Dirk Graf; Andreas Kislat; Bernhard Homey; Diran Herebian; Dieter Häussinger; Hartmut Hengel; Albert Zimmermann; Anna-Kathrin Schupp
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

4.  Interferon-γ-Producing CD4+ T Cells Drive Monocyte Activation in the Bone Marrow During Experimental Leishmania donovani Infection.

Authors:  Audrey Romano; Najmeeyah Brown; Helen Ashwin; Johannes S P Doehl; Jonathan Hamp; Mohamed Osman; Nidhi Dey; Gulab Fatima Rani; Tiago Rodrigues Ferreira; Paul M Kaye
Journal:  Front Immunol       Date:  2021-09-07       Impact factor: 7.561

5.  HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice.

Authors:  Jau-Hau Horng; Wei-Hsiang Lin; Chang-Ru Wu; You-Yu Lin; Li-Ling Wu; Ding-Shinn Chen; Pei-Jer Chen
Journal:  J Biomed Sci       Date:  2020-05-28       Impact factor: 8.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.